Gyan Chand Yadav

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2004-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gyan Chand Yadav. Retrieved from https://idiyas.com/inventor/gyan-chand-yadav

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Uttar Pradesh, IN (2004 - 2013)
Ghaziabad, IN (2011 - 2014)

Company Filing History:

4 out of 157

Ranbaxy Laboratories, Inc.

patents

Years Active: 2004-2014

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8754243 - Process for the preparation of 1, 2, 4-trioxolane antimalarials (2014-06-17),

2. 8569519 - Process for the preparation of dispiro 1,2,4-trioxolane antimalarials (OZ277) (2013-10-29),

3. 8026377 - Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt (2011-09-27),

4. 6833452 - Process for the preparation of highly pure crystalline (R,S)—cefuroxime axetil (2004-12-21),

Title: Gyan Chand Yadav: Innovator in Antimalarial Research

Introduction

Gyan Chand Yadav is a notable inventor based in India, recognized for his contributions to the field of antimalarial research. His innovative work focuses on developing effective treatments for malaria, schistosomiasis, and cancer.

Latest Patents

Yadav's significant patent is titled "Spiro And Dispiro 1,2,4-Trioxolane Antimalarials." This patent describes a means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane. The preferred compounds include a spiroadamantane group on one side of the trioxolane group and a spirocyclohexyl on the other side, with the spirocyclohexyl ring preferably substituted at the 4-position. Compared to artemisinin semisynthetic derivatives, the compounds of this invention are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites.

Career Highlights

Yadav is associated with Medicines for Malarial Venture (MMV), where he contributes to the development of new antimalarial therapies. His work is crucial in the ongoing fight against malaria, a disease that continues to affect millions worldwide.

Collaborations

Some of his notable coworkers include Jonathan L Vennerstrom and Yuanqing Tang, who collaborate with him in advancing research in antimalarial treatments.

Conclusion

Gyan Chand Yadav's innovative research and patent contributions play a vital role in the development of effective treatments for malaria and other diseases. His work exemplifies the importance of innovation in addressing global health challenges.

Profile summary based on public USPTO records.